{
  "event_id": "e742944efbcb",
  "ticker": "SRRK",
  "company_name": "Scholar Rock",
  "drug_name": "Apitegromab SRK-015",
  "pdufa_date": "2025-09-22",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:SAPPHIRE Phase 3 (BLA accepted, PDUFA Sep 2025)",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.628236",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "SMA Types 2 and 3",
    "source": "websearch:SAPPHIRE Phase 3 (BLA accepted, PDUFA Sep 2025)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.628237",
    "error": null
  },
  "generic_name": {
    "status": "not_searched",
    "value": null,
    "source": null,
    "confidence": 0.0,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "_reset_reason": "Was inferred from: final_mapping",
    "_reset_at": "2026-01-09T23:49:24.204703"
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Neurology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:59.102621",
    "error": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "derived_from_result",
    "confidence": 0.95,
    "tier": 1,
    "searched_sources": [
      "result_field"
    ],
    "last_searched": null,
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:SAPPHIRE Phase 3 (BLA accepted, PDUFA Sep 2025)",
    "confidence": 0.9,
    "evidence": [
      "SAPPHIRE Phase 3 (BLA accepted, PDUFA Sep 2025)"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.628223",
    "error": null
  },
  "p_value": {
    "status": "not_applicable",
    "value": null,
    "source": "websearch:SAPPHIRE Phase 3 (BLA accepted, PDUFA Sep 2025)",
    "confidence": 0.9,
    "evidence": [
      "Single-arm or accelerated approval - no comparator p-value"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.628230",
    "error": null
  },
  "p_value_numeric": null,
  "effect_size": {
    "status": "found",
    "value": "Motor function improvement sustained 36 months",
    "source": "websearch:SAPPHIRE Phase 3 (BLA accepted, PDUFA Sep 2025)",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.628232",
    "error": null
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "phase3_study_names": [
    "Phase 2 Active Treatment Study to Evaluate the Efficacy and Safety of SRK-015 in Patients With Later-Onset Spinal Muscular Atrophy (TOPAZ)",
    "Phase 3, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Apitegromab (SRK-015) in Patients With Later-Onset Spinal Muscular Atrophy Receiving Background Nusinersen or Risdiplam Therapy",
    "An Open-Label, Multicenter, Extension Trial to Evaluate the Long-Term Safety and Efficacy of Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab"
  ],
  "nct_ids": [
    "NCT03921528",
    "NCT05156320",
    "NCT05626855"
  ],
  "enrollment": {
    "count": 238,
    "type": "ACTUAL",
    "nct_id": "NCT05626855",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:30:51.345162"
  },
  "has_prior_crl": {
    "status": "found",
    "value": true,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "prior_crl_reason": {
    "status": "found",
    "value": "Third-party fill-finish facility (Catalent) inspection issues",
    "source": "web_search",
    "category": "CMC_ISSUE",
    "confidence": 0.9,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 1,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.85,
    "tier": 2
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "derived_from_crl_reason",
    "confidence": 0.75,
    "tier": 2
  },
  "result": "crl",
  "data_quality_score": 0.15,
  "collected_at": "2026-01-09T00:17:43.676557",
  "enriched_at": "2026-01-11T20:20:24.848726",
  "needs_manual_review": false,
  "review_reasons": [],
  "original_case_id": "a71b2d75e1af",
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "mechanism_of_action": "Myostatin inhibitor",
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "outcome": null,
    "vote": null
  },
  "days_to_pdufa": -110,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:42.217248",
  "adcom_scheduled": {
    "value": false,
    "status": "confirmed_none",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:45:40.379281"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_applicable",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:45:40.379289"
  },
  "breakthrough_therapy": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:20:04.995299",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:20:09.780433",
    "search_status": "CONFIRMED_NONE"
  },
  "priority_review": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:20:14.882432",
    "search_status": "CONFIRMED_NONE"
  },
  "fast_track": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:20:19.835081",
    "search_status": "CONFIRMED_NONE"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T20:20:24.848708",
    "search_status": "CONFIRMED_NONE"
  }
}